Active, not recruitingNCT06608251

Association of Plasma Metabolomic Biomarkers with Chronic Ischemic White Matter Injury

Studying Chronic graft versus host disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nanjing First Hospital, Nanjing Medical University
Principal Investigator
Ying Zhang, Doctor
Nanjing First Hospital, Nanjing Medical University
Intervention
white matter lesion(diagnostic_test)
Enrollment
100 target
Eligibility
45 years · All sexes
Timeline
20242025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06608251 on ClinicalTrials.gov

Other trials for Chronic graft versus host disease

Additional recruiting or active studies for the same condition.

See all trials for Chronic graft versus host disease

← Back to all trials